Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Young

Showing results (261-270 of 372) with videos related to

Pageof 38
Sort By:
Small (Weinheim an Der Bergstrasse, Germany)|December 21, 2012
Physicochemical and biological properties of biomimetic mineralo-protein nanoparticles formed spontaneously in biological fluidsHsin-Hsin Peng, Cheng-Yeu Wu, David Young, et al.
Wounds : a Compendium of Clinical Research and Practice|November 18, 2015
Clinical Experience and Best Practices Using Epidermal Skin Grafts on WoundsRobert S Kirsner, Brent Bernstein, Animesh Bhatia, et al.
Scientific Reports|February 15, 2017
Arabidopsis thaliana dehydroascorbate reductase 2: Conformational flexibility during catalysisNandita Bodra, David Young, Leonardo Astolfi Rosado, et al.
The Journal of Nutritional Biochemistry|April 27, 2013
Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J miceBanrida Wahlang, K Cameron Falkner, Bonnie Gregory, et al.
Attachment & Human Development|July 20, 2018
Reactive Attachment Disorder in maltreated young children in foster careMolly Bruce, David Young, Susan Turnbull, et al.
Journal of Molecular Biology|November 27, 2007
Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaBSudhiranjan Gupta, David Young, Ratan K Maitra, et al.
Anticancer Research|January 31, 2012
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapyFrank Richardson, G David Young, Regina Sennello, et al.
Frontline Gastroenterology|March 6, 2020
Early real-world effectiveness of ustekinumab for Crohn's diseaseRichard James Harris, Martin McDonnell, David Young, et al.
Cancers|November 27, 2025
Patient Perception of the Relevance of Quality-of-Life Questionnaires in Waldenström Macroglobulinaemia: An International SurveyJahanzaib Khwaja, Sotirios Bristogiannis, Ibrahim Tohidi-Esfahani, et al.
Maternal & Child Nutrition|June 20, 2019
Development of a biochemical marker to detect current breast milk intakeRuth Addison, Lauren Hill, Lars Bode, et al.
Pageof 38

Showing results (261-270 of 372) with videos related to

Sort By:
Pageof 38
Small (Weinheim an Der Bergstrasse, Germany)|December 21, 2012
Physicochemical and biological properties of biomimetic mineralo-protein nanoparticles formed spontaneously in biological fluidsHsin-Hsin Peng, Cheng-Yeu Wu, David Young, et al.
Wounds : a Compendium of Clinical Research and Practice|November 18, 2015
Clinical Experience and Best Practices Using Epidermal Skin Grafts on WoundsRobert S Kirsner, Brent Bernstein, Animesh Bhatia, et al.
Scientific Reports|February 15, 2017
Arabidopsis thaliana dehydroascorbate reductase 2: Conformational flexibility during catalysisNandita Bodra, David Young, Leonardo Astolfi Rosado, et al.
The Journal of Nutritional Biochemistry|April 27, 2013
Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J miceBanrida Wahlang, K Cameron Falkner, Bonnie Gregory, et al.
Attachment & Human Development|July 20, 2018
Reactive Attachment Disorder in maltreated young children in foster careMolly Bruce, David Young, Susan Turnbull, et al.
Journal of Molecular Biology|November 27, 2007
Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaBSudhiranjan Gupta, David Young, Ratan K Maitra, et al.
Anticancer Research|January 31, 2012
The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapyFrank Richardson, G David Young, Regina Sennello, et al.
Frontline Gastroenterology|March 6, 2020
Early real-world effectiveness of ustekinumab for Crohn's diseaseRichard James Harris, Martin McDonnell, David Young, et al.
Cancers|November 27, 2025
Patient Perception of the Relevance of Quality-of-Life Questionnaires in Waldenström Macroglobulinaemia: An International SurveyJahanzaib Khwaja, Sotirios Bristogiannis, Ibrahim Tohidi-Esfahani, et al.
Maternal & Child Nutrition|June 20, 2019
Development of a biochemical marker to detect current breast milk intakeRuth Addison, Lauren Hill, Lars Bode, et al.
Pageof 38